Translator Disclaimer
1 November 2008 Inhibition of Cyclooxygenase 2 in Mice Increases Production of G-CSF and Induces Radioprotection
M. Hofer, M. Pospíšil, J. Holá, A. Vacek, D. Štreitová, V. Znojil
Author Affiliations +
Abstract

Hofer, M., Pospíšil, M., Holá, J., Vacek, A., Štreitová, D. and Znojil, V. Inhibition of Cyclooxygenase 2 in Mice Increases Production of G-CSF and Induces Radioprotection. Radiat. Res. 170, 566–571 (2008).

Meloxicam, a selective inhibitor of cyclooxygenase 2, was tested to determine its ability to modulate hematopoiesis and to influence survival of mid-lethally γ-irradiated mice. A single dose of meloxicam (20 mg/kg) administered to mice intraperitoneally 1 h before irradiation was shown to enhance serum levels of granulocyte colony-stimulating factor (G-CSF) during the first 24 h after irradiation, to elevate numbers of granulocytic precursor cells in bone marrow and granulocyte counts in peripheral blood on day 10 after irradiation, and to increase 30-day survival of these mice. The results provide new evidence for the protective ability of meloxicam administration to mice irradiated with mid-lethal doses and contribute to the understanding of the mechanisms of this meloxicam action by drawing attention to the possible role of increased endogenous G-CSF production.

M. Hofer, M. Pospíšil, J. Holá, A. Vacek, D. Štreitová, and V. Znojil "Inhibition of Cyclooxygenase 2 in Mice Increases Production of G-CSF and Induces Radioprotection," Radiation Research 170(5), 566-571, (1 November 2008). https://doi.org/10.1667/RR1387.1
Received: 7 March 2008; Accepted: 1 June 2008; Published: 1 November 2008
JOURNAL ARTICLE
6 PAGES


Share
SHARE
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top